Annual Total Long Term Liabilities
$105.59 M
+$15.33 M+16.98%
31 December 2023
Summary:
CymaBay Therapeutics annual total long term liabilities is currently $105.59 million, with the most recent change of +$15.33 million (+16.98%) on 31 December 2023. During the last 3 years, it has risen by +$54.57 million (+106.97%).CBAY Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$105.59 M
+$396.00 K+0.38%
31 December 2023
Summary:
CymaBay Therapeutics quarterly total long term liabilities is currently $105.59 million, with the most recent change of +$396.00 thousand (+0.38%) on 31 December 2023.CBAY Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CBAY Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | +107.0% | +107.0% |
| 5 y5 years | +5957.8% | +5957.8% |
CBAY Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -66.9% | at high |
CymaBay Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $105.59 M(+17.0%) | $105.59 M(+0.4%) |
| Sept 2023 | - | $105.19 M(+4.8%) |
| June 2023 | - | $100.35 M(+6.0%) |
| Mar 2023 | - | $94.63 M(+4.8%) |
| Dec 2022 | $90.26 M(+76.9%) | $90.26 M(+4.5%) |
| Sept 2022 | - | $86.36 M(+4.4%) |
| June 2022 | - | $82.71 M(+4.4%) |
| Mar 2022 | - | $79.22 M(+55.3%) |
| Dec 2021 | $51.02 M(+3942.4%) | $51.02 M(+111.7%) |
| Sept 2021 | - | $24.10 M(+2339.6%) |
| June 2021 | - | $988.00 K(-12.3%) |
| Mar 2021 | - | $1.13 M(-10.7%) |
| Dec 2020 | $1.26 M(-27.6%) | $1.26 M(-9.1%) |
| Sept 2020 | - | $1.39 M(-8.1%) |
| June 2020 | - | $1.51 M(-7.3%) |
| Mar 2020 | - | $1.63 M(-6.5%) |
| Dec 2019 | $1.74 M(-8.9%) | $1.74 M(-5.8%) |
| Sept 2019 | - | $1.85 M(-5.3%) |
| June 2019 | - | $1.95 M(-4.8%) |
| Mar 2019 | - | $2.05 M(+7.3%) |
| Dec 2018 | $1.91 M | $1.91 M(-1.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2018 | - | $1.94 M(-5.0%) |
| June 2018 | - | $2.04 M(-4.8%) |
| Mar 2018 | - | $2.14 M(-28.4%) |
| Dec 2017 | $2.99 M(-51.1%) | $2.99 M(-21.6%) |
| Sept 2017 | - | $3.81 M(-17.2%) |
| June 2017 | - | $4.61 M(-14.3%) |
| Mar 2017 | - | $5.37 M(-12.1%) |
| Dec 2016 | $6.11 M(-30.7%) | $6.11 M(-10.4%) |
| Sept 2016 | - | $6.82 M(-9.2%) |
| June 2016 | - | $7.51 M(-8.1%) |
| Mar 2016 | - | $8.18 M(-7.3%) |
| Dec 2015 | $8.82 M(+178.6%) | $8.82 M(-4.3%) |
| Sept 2015 | - | $9.22 M(+276.9%) |
| June 2015 | - | $2.44 M(-12.6%) |
| Mar 2015 | - | $2.80 M(-11.6%) |
| Dec 2014 | $3.17 M(-28.3%) | $3.17 M(-9.2%) |
| Sept 2014 | - | $3.49 M(-8.2%) |
| June 2014 | - | $3.80 M(-11.6%) |
| Mar 2014 | - | $4.30 M(-2.6%) |
| Dec 2013 | $4.42 M(-98.6%) | $4.42 M |
| Dec 2012 | $318.73 M | - |
FAQ
- What is CymaBay Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for CymaBay Therapeutics?
- What is CymaBay Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for CymaBay Therapeutics?
What is CymaBay Therapeutics annual total long term liabilities?
The current annual total long term liabilities of CBAY is $105.59 M
What is the all time high annual total long term liabilities for CymaBay Therapeutics?
CymaBay Therapeutics all-time high annual total long term liabilities is $318.73 M
What is CymaBay Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of CBAY is $105.59 M
What is the all time high quarterly long term liabilities for CymaBay Therapeutics?
CymaBay Therapeutics all-time high quarterly total long term liabilities is $105.59 M